1. Home
  2. XBIT vs NRT Comparison

XBIT vs NRT Comparison

Compare XBIT & NRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.36

Market Cap

74.4M

Sector

Health Care

ML Signal

HOLD

NRT

North European Oil Royality Trust

HOLD

Current Price

$7.19

Market Cap

66.0M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIT
NRT
Founded
2005
1975
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
74.4M
66.0M
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
XBIT
NRT
Price
$2.36
$7.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
29.4K
46.1K
Earning Date
05-08-2026
05-29-2026
Dividend Yield
N/A
10.18%
EPS Growth
N/A
N/A
EPS
N/A
0.43
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$16.63
Revenue Growth
N/A
N/A
52 Week Low
$2.09
$4.76
52 Week High
$3.61
$10.49

Technical Indicators

Market Signals
Indicator
XBIT
NRT
Relative Strength Index (RSI) 46.97 45.52
Support Level $2.26 $6.91
Resistance Level $2.49 $8.68
Average True Range (ATR) 0.05 0.30
MACD 0.01 0.02
Stochastic Oscillator 29.59 54.85

Price Performance

Historical Comparison
XBIT
NRT

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About NRT North European Oil Royality Trust

North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.

Share on Social Networks: